Skip to main content
Clinical Trials/CTRI/2022/12/048114
CTRI/2022/12/048114
Recruiting
N/A

Rehabilitative effectiveness of visuo-stimulation, visuo-motor and visuo-perceptual learning interventions in improving neuro-visuo-cognitive behaviour in children with CVI compared to standard care: A randomised control pilot study

o sponsor0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
o sponsor
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
o sponsor

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria includes
  • 1\. patients with history and documentation of perinatal asphyxia, periventricular leukomalacia, hypoglycemia, perinatal infections, genetic, metabolic, hydrocephalus, or structural causes or
  • 2\. documented perinatal brain damage confirmed by a pediatric neurologist along with
  • 3\. MRI evidence of brain injury in a pattern typical of hypoxic\-ischemic encephalopathy (HIE) including peri\-ventricular leukomalacia (PVL)
  • 4\. problems in visual functioning (corroborated by results of functional vision assessment) or atypical neuro\-visuo\-behavior or visual perceptual or cognitive dysfunction on CVI inventory questionnaire and
  • 5\. confirmed on examination with at least 2 or more of the following: a) Deficit or impaired visual inattention, fixation, or inability to follow objects; b)Deficit visual guided reach or visual guidance of upper limbs (inability to reach out or hold a toy or difficulty in picking up a toy); c) Deficit visual communication/search/curiosity/ spatial orientation; d)Deficit visual processing like recognition of face/objects/facial expression or Difficulty with clutter

Exclusion Criteria

  • Children with pediatric cataracts, corneal pathologies, retinal pathologies, or dense amblyopia responsible for low vision
  • Retinopathy of prematurity of grade 4 or 5, and major ROP sequelae like falciform fold involving disc or macula nonresolving macular bleed, vitreous hemorrhage assessed by a paediatric ophthalmologist
  • Children with epileptic spasms, electroclinical epileptic encephalopathy, seizure frequency of more than one/month in the past 3 months or patients using anti\-epileptic vigabatrin
  • Children with debilitating illnesses requiring immediate attention
  • Children whose caregivers refuse to participate in the study
  • Autistic children

Outcomes

Primary Outcomes

Not specified

Similar Trials